Invest in Israel Newsletter March 2010 Edition
VC Cafe
APRIL 8, 2010
US drug powerhouse Pfizer and Iceland-based Actavis were among the bidders in the final round, but Teva beat their offers. The British mobile payments and messaging aggregator will become part of Amdocs’ OpenMarket US mobile transactions hub. The deal is expected to capture significant synergies for Teva.
Let's personalize your content